Spontaneous Intracranial Hypotension Treatment "SIHT"

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT02261792
Collaborator
(none)
64
1
2
75.2
0.9

Study Details

Study Description

Brief Summary

Spontaneous intracranial hypotension (SIH) is an infrequent disease, related to a leak of cerebrospinal fluid. There are not controlled studies for this treatment.The main of this study is to demonstrate the superiority of the Trendelenburg position compared to supine position during 24 hours after an epidural blood patch for a spontaneous intracranial hypotension

Condition or Disease Intervention/Treatment Phase
  • Procedure: 24 hours Trendelenburg position
  • Procedure: 24 hours bed rest
  • Procedure: EBP
N/A

Detailed Description

Various treatments have been used for patient with spontaneous intracranial hypotension, but there is not definite approach. Some patients, fortunately, improve spontaneously. Bed rest and increased fluid intake have been advocate. The effectiveness of the caffeine has been shown in some studies, but durable beneficial effect is doubtful. The efficacy of steroids has not been established. However, although there have been no controlled studies, autologous epidural blood patch (EBP) can be considered the treatment of choice for patients. The success rate of EBP for a post lumbar puncture headache is about 90%, but for SIH, is very less about 50% after the first one and 77% after the second. The amount of blood injected must be sufficient. On the other hand, the leak is usually located on dorsal, above the prolonged rest must be respected. One study, have demonstrated, without randomization, a success rate of 90% with a prolonged Trendelenburg after EBP. We decided to do this study, to confirm a superiority of a 24 hours prolonged Trendelenburg position.

It's a monocentric study of parallel randomized open blind groups. Patients will be recruited by investigators in our headache emergency room. If the diagnose of SIH is confirmed (orthostatic headache from more than 5 days and less than 28 days with a normal MRI or with sign of SIH) study will be proposed.

After a signed information, the patients will be randomized in 2 groups, the investigator is blind of the randomized arm of patient

  1. EBP with 24 hours bed rest

  2. EBP with 24 hours Trendelenburg position

V1: inclusion V2 : 24 hours before EBP (headache, associated symptoms, HIT6) V3 :

randomization and EBP V4 : first evaluation 30 minutes after standing (headaches, associated symptoms) V5 : phone evaluation (safety) D7 V6 : Evaluation at D15 (headache, associated symptoms, safety) V7 : Evaluation at D30 (headache, associated symptoms, control cerebral MRI, HIT6, safety) V8 : last evaluation D60 (headache, associated symptoms,HIT6 safety)

Collection of 2nd EBP, 3rd EBP, 4th EBP throughout the study up to J 92 maximum

Study Design

Study Type:
Interventional
Actual Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Parallel Randomised Open Blind Evaluation Study of the Efficacy of 20° Trendelenburg Position During 24 Hours After Epidural Blood Patch in the Treatment of Spontaneous Intracranial Hypotension
Actual Study Start Date :
Dec 1, 2014
Actual Primary Completion Date :
Oct 1, 2020
Actual Study Completion Date :
Mar 8, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: A : 24 hours bed rest

24 hours bed rest

Procedure: 24 hours bed rest
24 hours bed rest after EBP
Other Names:
  • Allitement flat position for 24 hours
  • Procedure: EBP
    Autologous Epidural Blood Patch
    Other Names:
  • Epidural Blood Patch
  • Experimental: B : 24 hours Trendelenburg position

    24 hours Trendelenburg position

    Procedure: 24 hours Trendelenburg position
    Trendelenburg position
    Other Names:
  • inclination of the body at 20 degrees
  • Procedure: EBP
    Autologous Epidural Blood Patch
    Other Names:
  • Epidural Blood Patch
  • Outcome Measures

    Primary Outcome Measures

    1. Recovery at Day 1 without relapse at Day 15 [Day 1]

      V4: first evaluation 30 minutes after standing (headaches, associated symptoms) V6 : Evaluation at D15 (headache, associated symptoms, safety)

    2. Recovery at Day 1 without relapse at Day 15 [day 15]

      V4: first evaluation 30 minutes after standing (headaches, associated symptoms) V6 : Evaluation at D15 (headache, associated symptoms, safety)

    Secondary Outcome Measures

    1. 2d EBP and other EBP [day 7, 15, 30 and 60]

      Number of patients requires a treatment with a second BP at any time of study (withdrawal study)

    2. Associated symptoms [day 1, 15, 30 and 60]

      Disappearance of associated symptoms

    3. Headache [day 1,15, 30 and 60]

      Pain scores, localisation and type of persistent headache at day 1,15, 30 and 60

    4. subdural hematoma surgery [day 7, 15, 30 and 60]

      Number of patients requires a surgery for life-threatening acute SDH

    5. cerebral MRI [day 30]

      results of D30 control MRI, compared to baseline MRI

    6. medullar MRI [day 60]

      results of baseline medullar MRI and the link between leak and patient recovery

    7. Epidural Blood Patch [day 60]

      Volume of blood and localisation of injection / statistical data related with recovery

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years or more

    • No contraindication for BPE

    • Severe or moderate headache within 15 min standing, mild or no headache after 15 min bed rest

    • Headache from 5 to 28 days

    • Normal or evidence of low CSF on MRI

    • Signed informed consent

    Exclusion Criteria:
    • Known dural leak in the previous 2 months the onset of headache

    • Abnormal MRI

    • First BPE for SIH

    • The patient has participated in another clinical trial than can interact with the evaluation

    • Contraindication of Trendelenburg position

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Lariboisiere Hospital - Centre Urgences Céphalées (CUC) Paris France 75010

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: Caroline ROOS, MD, Assistance Publique - Hôpitaux de Paris

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT02261792
    Other Study ID Numbers:
    • P111118
    • 2013-AO1017-38
    First Posted:
    Oct 10, 2014
    Last Update Posted:
    Apr 21, 2022
    Last Verified:
    Apr 1, 2022

    Study Results

    No Results Posted as of Apr 21, 2022